ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $326,000 | -43.4% | 20,000 | -55.6% | 0.06% | -42.0% |
| Q4 2017 | $576,000 | +4.0% | 45,000 | 0.0% | 0.10% | 0.0% |
| Q3 2017 | $554,000 | +10.4% | 45,000 | -25.0% | 0.10% | +5.3% |
| Q2 2017 | $502,000 | -6.3% | 60,000 | 0.0% | 0.10% | -6.9% |
| Q1 2017 | $536,000 | +1.7% | 60,000 | 0.0% | 0.10% | -2.9% |
| Q4 2016 | $527,000 | +30.1% | 60,000 | 0.0% | 0.10% | +25.0% |
| Q3 2016 | $405,000 | +89.3% | 60,000 | 0.0% | 0.08% | +86.7% |
| Q2 2016 | $214,000 | +13.2% | 60,000 | 0.0% | 0.04% | +12.5% |
| Q1 2016 | $189,000 | -25.3% | 60,000 | 0.0% | 0.04% | -23.1% |
| Q4 2015 | $253,000 | -7.7% | 60,000 | 0.0% | 0.05% | -11.9% |
| Q3 2015 | $274,000 | -36.7% | 60,000 | 0.0% | 0.06% | -29.8% |
| Q2 2015 | $433,000 | -2.0% | 60,000 | 0.0% | 0.08% | -1.2% |
| Q1 2015 | $442,000 | +55.6% | 60,000 | 0.0% | 0.08% | +54.5% |
| Q4 2014 | $284,000 | +32.7% | 60,000 | 0.0% | 0.06% | +25.0% |
| Q3 2014 | $214,000 | -21.9% | 60,000 | 0.0% | 0.04% | -18.5% |
| Q2 2014 | $274,000 | -2.8% | 60,000 | 0.0% | 0.05% | -6.9% |
| Q1 2014 | $282,000 | – | 60,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |